The FTC Healthcare Task Force: What It Means for Med Spas and Clinics

On March 20, 2026, FTC Chairman Andrew N. Ferguson directed the agency's staff to form a Healthcare Task Force. Much of the early commentary made it sound like a new enforcement regime. The memo itself is more modest: it is an internal coordination body, not a new law or rule.

For med spas, clinics and telehealth businesses, the more useful question is what kinds of healthcare conduct the FTC has actually been pursuing. This guide covers what the memo says, the consumer protection cases most relevant to smaller practices, and the areas worth reviewing first.

What the memo actually says

The directive went to the Bureau of Competition, the Bureau of Consumer Protection, the Bureau of Economics, the Office of Policy Planning and the Office of Technology. According to the memo:

The task force is co-chaired by one representative each from the competition and consumer protection bureaus.
It includes at least three members from each bureau, plus members from the policy planning, technology and general counsel offices.
It meets at least monthly and reports to the Chairman quarterly.
Its job is to share knowledge, case leads and market intelligence across the agency, lead targeted enforcement and advocacy initiatives, plan strategy for new investigations, look for opportunities to file amicus briefs and statements of interest, and scan for emerging issues.
It will seek to add partners from other agencies, including the Department of Health and Human Services and the Department of Justice.

The memo ties the effort to a February 2025 executive order on healthcare price transparency and frames healthcare as a priority because of its size, roughly 18 percent of GDP, and concerns about consolidation, prices and access.

What it does not say

The memo does not create new legal obligations, set specific enforcement targets for small practices, or announce a new investigative process. Law firm commentary has noted that it is light on operational detail. Claims that the task force lets the FTC fold every issue into one sweeping investigation, or that it imposes new pricing or documentation requirements on providers, go beyond what the FTC has published.

It is also worth being clear about one comparison that circulated after the announcement. The FTC sent warning letters about deceptive pricing to 97 auto dealership groups in March 2026. Those letters concern car dealers and do not set any precedent for healthcare providers.

The track record the FTC pointed to

To explain why healthcare matters, the memo listed recent wins. On the competition side: a settlement with pharmacy benefit manager Express Scripts, a successful challenge to Edwards' proposed acquisition of JenaValve, the abandoned Alcon and Lensar merger in cataract surgery lasers, and challenges to improperly listed drug device patents.

The consumer protection examples are the ones closer to day-to-day practice:

$145 million in redress from companies the FTC alleged misled consumers shopping for health insurance into buying indemnity, telemedicine and discount plans.
A $2.4 million settlement with substance-abuse treatment facilities that, according to the FTC, used telemarketers to impersonate other facilities and steer patients to their own.
An action against a telehealth weight-loss company over deceptive cost and weight-loss claims and fake reviews.
Refunds to consumers who bought products marketed with claims that they could treat or cure diseases such as COVID-19 and cancer.

Two cases worth reading closely

NextMed (2025). The telehealth weight-loss case in the memo appears to be NextMed, a GLP-1 weight-loss program. In July 2025 the FTC alleged that NextMed advertised monthly fees of about $138 or $188 without clearly disclosing that the price excluded the medication, required lab work and the provider consultation. It also alleged an undisclosed one-year commitment with an early termination fee, unsupported claims that members lose 53 pounds and 23 percent of body weight on average, testimonials and before-and-after photos from people who were not customers, and review manipulation, including offering gift cards to change negative reviews and conditioning refunds on removing them. The final order, approved in December 2025, requires $150,000 for refunds and bans misrepresenting costs, requires evidence for typical-results claims, bans review manipulation, and requires informed consent before billing plus clear refund and cancellation terms.

TruHeight (2026). Less than a month after the task force launched, the FTC charged supplement seller TruHeight with making unsupported height-growth claims for children and teens and with using fake and incentivized reviews and bot-run social media profiles. The order was finalized in July 2026, with a $4 million judgment suspended after a $750,000 payment.

Neither case involved a med spa, both were resolved by settlement, and the allegations are the FTC's. But the conduct alleged (headline prices that leave out required costs, average-results claims without evidence, staged testimonials, review manipulation) maps directly onto how many aesthetic and wellness practices market memberships, weight-loss programs and packages.

Where practices often look first

Based on the cases above, these are the areas businesses in aesthetics, wellness and telehealth commonly review:

Advertised prices. If a price shown in an ad excludes the medication, consult, labs or required add-ons, make that clear where the price appears, not only at checkout.
Memberships and recurring billing. The FTC's broader "click to cancel" rule was vacated by a federal appeals court in July 2025, but the Restore Online Shoppers' Confidence Act still requires clear disclosure of material terms, express informed consent and a simple way to cancel for online subscriptions.
Results claims. Average weight loss, "inches lost," or similar numbers need evidence that applies to your program and your patients.
Testimonials and before-and-after photos. They should come from real patients who actually had the treatment, with any compensation or discount disclosed.
Reviews. The FTC's consumer reviews rule, in effect since October 21, 2024, bans fake reviews, incentives tied to positive or negative sentiment, and suppressing negative reviews through threats or misleading displays.
Lead generation and call handling. Callers, chat agents and ads should never imply they represent a different practice or provider.

On penalties: most first-time FTC cases end in orders and redress rather than fines, but violations of an FTC rule such as the reviews rule, or of an existing order, can bring civil penalties of up to $53,088 per violation. That 2025 figure stays in place for 2026 after the FTC confirmed in September 2026 that the 2026 inflation adjustment was cancelled.

What to watch

The task force reports to the Chairman quarterly, but those reports are internal. The practical signals are FTC press releases on healthcare cases, joint work with HHS or DOJ, and any business guidance aimed at telehealth or aesthetics. Questions about a specific program, especially GLP-1 or other prescription offerings, are worth taking to healthcare counsel.

Where NutriCove fits

NutriCove builds AI automation for med spas: an AI receptionist, missed-call text back, follow-ups, booking and review requests. Those tools send messages on the practice's behalf, so the pricing, results and review practices covered above apply to what they say. If you're setting up automated follow-up or review requests, see how we build med spa automation.

Sources

This article is general information, not legal or medical advice. Talk to a qualified attorney or licensed professional about your situation.